GUEST COLUMN: Private sector has powerful incentive to treat opioid addiction
From The Washington Post — May 14
In the steadily growing U.S. economy, with tax reform and regulatory relief leading businesses to invest more in both facilities and people, the unemployment rate stands at 3.9 percent, the lowest since 2000.
A record number of business owners say now is a good time to expand, but our workforce needs are going unmet. I see this in Ohio, where employers increasingly tell me that their biggest challenge is finding workers.
Some new data suggest that the most significant factor contributing to this labor-force decline is the opioid epidemic.
Last year, a Brookings Institution report found that about half of men age 25 to 54 not in the labor force take pain medication daily, and nearly two-thirds of that group take prescription pain medication. This year, a Labor Department survey found that 44 percent of men in this age group who were out of the labor force acknowledged taking pain medication the previous day. The true number is likely higher than that because of the stigma and the legal risk involved in admitting drug use.
Addiction takes over lives, strips affected Americans of their ambition and tears at the very fabric of our society. It is also undermining our economy at a time when workers are badly needed.
In the past two years, Congress has taken important steps to address the crisis. The 2016 Comprehensive Addiction and Recovery Act, or CARA, provides resources for evidence-based prevention, treatment and recovery programs to help break the cycle of addiction. The 21st Century Cures Act, passed later that year, and the recent budget agreement provide to states unprecedented funding to combat the opioid epidemic. And the recently introduced CARA 2.0 will ensure additional funding is well spent on evidence-based programs.
While Washington has a role to play in addressing this crisis, it will ultimately be solved at the local level. Everyone has a role to play, including business leaders. It is time for them to step up in a more significant way with solutions within their companies and in their cities and towns.
One significant issue is the over-prescription of pain pills. About 80 percent of heroin users start with prescription drugs. CARA 2.0 will limit opioid prescriptions to three days for acute pain based on guidelines from the Centers for Disease Control and Prevention. Some medical associations and drug companies are pushing back against this proposal, but businesses don’t have to wait for legislation to act. A few companies already have changed their prescription policies; more should join.
I’ve also seen the positive contributions an engaged private sector can make at the local level. At the new Maryhaven Addiction Stabilization Center in Columbus, Ohio, private-sector funding — including business support — combined with funding from Congress is being used to try something innovative: The center offers longer-term treatment in the same facility where it performs overdose reversal and stabilization.
The private sector should also join in a national prevention and education campaign. An effective online, print and broadcast campaign is needed to save lives.
Overdose statistics and high rates of addiction among those out of work aren’t just numbers — they represent people with broken dreams. Based on the clear impact opioids are having on workforce availability, the private sector has every incentive to step up. We all have a role to play in getting people off the sidelines and back to productive lives so they can live up to their God-given potential.